April 13, 2021

PR Headline News

Top Stories Without The Fluff

WHO calls for Covid-19 vaccine to be a universal health product | PRESENT


In the opinion of the director general of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, there should be a “global consensus” to make any vaccine against the new coronavirus a universal health product.

He stressed that doing so is a "political choice" since "nationalism" will not help combat the pandemic. "Vaccine nationalism is not good, it will not help us," stressed Abhanom Ghebreyesus. “When we say that it should be a public good, it is not just for sharing, it is because it has advantages,” he added, explaining that in this way we will all recover faster because we live in “a globalized world.”

During a panel discussion In line with members of the Aspen Safety Forum, the organization's director hinted at the competitive struggle of nations and pharmaceuticals to find an effective vaccine and market as many doses in advance. By sharing vaccines or other tools, "economic recovery can be faster and damage from covid-19 could be less," said the WHO diplomatic leader.

In this way, he expressed the need for richer countries make a political commitment to ensure that any preparation is fairly distributed worldwide.

This week, WHO declared that it will guarantee access to the Covid-19 vaccine for all countries through the COVAX mechanism. [19659002] This system "is accelerating the search for an effective vaccine for all countries", while seeking to "guarantee rapid, fair and equitable access" to it all over the world, "explained a spokesperson for the agency.

Recent Bloomberg report showed that the United States, the United Kingdom, the European Union and Japan have already reserved around 1.3 billion doses of "possible means of immunization against Covid-19", so there is "growing concern" The idea that the rest of the world will be at the end of the queue in the global effort to defeat the pathogen. ”

For its part, China announced that it will grant a credit of 1,000 million dollars to the countries of Latin America and the Caribbean that will allow access to the vaccine against covid-19. The Asian giant has expressed on several occasions that the preparation developed in its country will be a public good with universal access.



Source link